CARA - Cara Therapeutics Inc
IEX Last Trade
0.3525
0.001 0.284%
Share volume: 194,418
Last Updated: Fri 30 Aug 2024 09:18:40 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$0.35
0.00
0.28%
Summary score
37%
Profitability
25%
Dept financing
11%
Liquidity
75%
Performance
45%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.47%
Return on assets
-12.6%
Return on sales
-791.01%
Return on invested capital
180.92%
Total debt ratio
18.23%
Debt ratio change over timeo
-1.23%
Current Ratio
7.85%
Quick Ratio
7.9%
Cash Position Ratio
6.76%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-55.32%
Return on assets
-26.32%
Return on sales
-855.71%
Return on invested capital
310.01%
Total debt ratio
41.56%
Debt ratio change over timeo
-0.85%
Current Ratio
4.8%
Quick Ratio
4.66%
Cash Position Ratio
3.93%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-103%
Return on assets
-30.26%
Return on sales
-1277.05%
Return on invested capital
493.43%
Total debt ratio
66.92%
Debt ratio change over time
-0.67%
Current Ratio
5.38%
Quick Ratio
5.2%
Cash Position Ratio
4.62%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.67%
Return on assets
-93.43%
Return on sales
548.97%
Return on invested capital
74.1%
Total debt ratio
-122.98%
Debt ratio change over time
-1.23%
Current Ratio
-34.09%
Quick Ratio
-35.8%
Cash Position Ratio
-29.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CARA | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -20.47% | 18.83% | 17.34% | 7.6% |
| Return on assets | -12.6% | 4.16% | 8.21% | 3.22% |
| Return on sales | -791.01% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 180.92% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 56% | 73% | 36% |
| Total debt ratio | 18.23% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -1.23% | -4.38% | -0.73% | -33.74% |
| Dept financing | 5% | 25% | 42% | 18% |
| Current Ratio | 4.8% | 1.12% | 0% | 1.16% |
| Quick Ratio | 4.66% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 3.93% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 8% | 7% | 10% |
| Short-term ratios | CARA | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -55.32% | 13.31% | 0% | 13.48% |
| Return on assets | -26.32% | 4.72% | 0% | 3.05% |
| Return on sales | -855.71% | 31.4% | 0% | 25.56% |
| Return on invested capital | 310.01% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 76% | 0% | 63% |
| Total debt ratio | 41.56% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -0.85% | -41.82% | 0% | 7.13% |
| Dept financing | 13% | 25% | 0% | 43% |
| Current Ratio | 4.8% | 1.12% | 0% | 1.16% |
| Quick Ratio | 4.66% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 3.93% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 11% | 0% | 14% |